Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02797704Phase 1/2Terminated
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Corneal Neovascularization
PrincipalinvestigatorStart date: 2017-03-02

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Head of ophthalmology department

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hernández-Quintela Everardo, MD

Consejo Nacional de Ciencia y Tecnología (CONACYT) grant no. 115755 (EHQ)

Moderately Similar
1 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Michael J Mines, MD

Walter Reed Army Medical Center

Moderately Similar
2 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Francis W Price, Jr., MD

Price Vision Group

Moderately Similar
5 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Ching-Hsi Hsiao, MD

Chang Gung Memorial Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

John D. Sheppard

Eastern Virginia Medical School

Moderately Similar
1 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Reza Dana, MD, MPH, MSc

Massachusetts Eye and Ear Infirmary

Moderately Similar
6 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Balamurali Ambati, M.D., Ph.D., M.B.A.

University of Utah

Moderately Similar
1 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Sang Woo Kim, M.D.

Severance hospital, Seoul , Korea

Moderately Similar
1 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Sonia Yoo, MD

Bascom Palmer Eye Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Reza Dana, M.D., MPH

Massachusetts Eye and Ear Infirmary

Moderately Similar
2 trials

Shared therapeutic areas:

Corneal Neovascularization
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02797704Phase 1/2PrincipalInvestigator

Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization

Corneal Neovascularization
Terminated

All 1 trials loaded